Wagner Bowman Management Corp boosted its holdings in shares of CVS Health Corp (NYSE:CVS) by 5.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,579 shares of the pharmacy operator’s stock after purchasing an additional 1,083 shares during the quarter. Wagner Bowman Management Corp’s holdings in CVS Health were worth $1,282,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of CVS Health by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after acquiring an additional 1,445,887 shares during the last quarter. Vanguard Group Inc boosted its position in CVS Health by 1.7% during the 3rd quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after purchasing an additional 1,445,887 shares during the period. BlackRock Inc. boosted its position in CVS Health by 2.8% during the 3rd quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after purchasing an additional 2,061,915 shares during the period. FMR LLC boosted its position in CVS Health by 4.3% during the 3rd quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after purchasing an additional 1,250,473 shares during the period. Finally, Dodge & Cox acquired a new position in CVS Health during the 3rd quarter valued at approximately $1,190,694,000. Institutional investors own 87.22% of the company’s stock.

CVS stock traded up $0.28 during trading on Monday, reaching $65.29. 1,786,857 shares of the company’s stock were exchanged, compared to its average volume of 9,257,786. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.94 and a current ratio of 2.44. CVS Health Corp has a 1-year low of $60.14 and a 1-year high of $82.15. The firm has a market capitalization of $66.23 billion, a PE ratio of 11.07, a price-to-earnings-growth ratio of 0.88 and a beta of 1.03.

The firm also recently declared a quarterly dividend, which was paid on Monday, February 4th. Shareholders of record on Friday, January 25th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, January 24th. This represents a $2.00 dividend on an annualized basis and a yield of 3.06%. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.

CVS has been the subject of a number of analyst reports. Royal Bank of Canada set a $99.00 price objective on CVS Health and gave the company a “buy” rating in a research report on Tuesday, October 23rd. Wolfe Research initiated coverage on CVS Health in a research report on Thursday, October 25th. They set a “peer perform” rating for the company. Tigress Financial restated a “buy” rating on shares of CVS Health in a research report on Friday, October 26th. ValuEngine upgraded CVS Health from a “sell” rating to a “hold” rating in a research report on Wednesday, October 31st. Finally, Morgan Stanley set a $100.00 price objective on CVS Health and gave the company a “buy” rating in a research report on Wednesday, November 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and thirteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $91.79.

In other CVS Health news, EVP Troyen A. Brennan sold 14,229 shares of the business’s stock in a transaction on Wednesday, November 14th. The stock was sold at an average price of $82.00, for a total transaction of $1,166,778.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Jonathan C. Roberts sold 77,639 shares of the business’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $64.54, for a total value of $5,010,821.06. The disclosure for this sale can be found here. Insiders have sold a total of 449,763 shares of company stock valued at $30,412,036 in the last quarter. 0.53% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “Wagner Bowman Management Corp Has $1.28 Million Holdings in CVS Health Corp (CVS)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2019/02/11/wagner-bowman-management-corp-has-1-28-million-holdings-in-cvs-health-corp-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: Price to Earnings Ratio (PE), For Valuing Stocks

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.